Infinity Pharma (INFI) Posts Mixed Q2 Results

August 9, 2016 4:49 PM EDT
Get Alerts INFI Hot Sheet
Trade INFI Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of $1.05, $1.94 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $13.91 million.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment